{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:57:22Z","timestamp":1793087842883,"version":"4.5.0"},"reference-count":107,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T00:00:00Z","timestamp":1714348800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020019","name":"University of Oulu Biocenter","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020019","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005633","name":"Syd\u00e4ntutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.biopha.2024.116683","type":"journal-article","created":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T07:38:33Z","timestamp":1714808313000},"page":"116683","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Inhibition of activin receptor 2 signalling ameliorates metabolic dysfunction\u2013associated steatotic liver disease in western diet\/L-NAME induced cardiometabolic disease"],"prefix":"10.1016","volume":"175","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8831-616X","authenticated-orcid":false,"given":"Julia","family":"Swan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0778-1113","authenticated-orcid":false,"given":"Zolt\u00e1n","family":"Szab\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6631-4874","authenticated-orcid":false,"given":"Juliana","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0327-3496","authenticated-orcid":false,"given":"Outi","family":"Kummu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kemppi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Rahtu-Korpela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9758-6164","authenticated-orcid":false,"given":"Anja","family":"Konzack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5048-4363","authenticated-orcid":false,"given":"Jukka","family":"Hakkola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6088-4245","authenticated-orcid":false,"given":"Arja","family":"Pasternack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olli","family":"Ritvos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7194-9326","authenticated-orcid":false,"given":"Risto","family":"Kerkel\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4688-9098","authenticated-orcid":false,"given":"Johanna","family":"Magga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.biopha.2024.116683_bib1","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"issue":"10159","key":"10.1016\/j.biopha.2024.116683_bib2","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"James","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.biopha.2024.116683_bib3","first-page":"13","article-title":"Health effects of overweight and obesity in 195 countries over 25 years. GBD 2015 Obesity Collaborators","volume":"377","author":"Afshin","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.biopha.2024.116683_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.15420\/cfr.2016:25:2","article-title":"Global public health burden of heart failure","volume":"3","author":"Savarese","year":"2017","journal-title":"Card. Fail. Rev."},{"issue":"20","key":"10.1016\/j.biopha.2024.116683_bib5","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1093\/eurheartj\/ehy005","article-title":"Mortality associated with heart failure with preserved vs. reduced ejection fraction in a prospective international multi-ethnic cohort study","volume":"39","author":"Lam","year":"2018","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.biopha.2024.116683_bib6","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/s41569-020-00480-6","article-title":"Cellular and molecular pathobiology of heart failure with preserved ejection fraction","volume":"18","author":"Mishra","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"issue":"12","key":"10.1016\/j.biopha.2024.116683_bib7","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1161\/CIRCULATIONAHA.119.041886","article-title":"Research priorities for heart failure with preserved ejection fraction","volume":"141","author":"Shah","year":"2020","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.biopha.2024.116683_bib8","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.biopha.2024.116683_bib9","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41569-020-0363-2","article-title":"Evaluation and management of heart failure with preserved ejection fraction","volume":"17","author":"Borlaug","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"issue":"5","key":"10.1016\/j.biopha.2024.116683_bib10","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.cjca.2018.02.026","article-title":"Heart failure with preserved ejection fraction in diabetes: mechanisms and management","volume":"34","author":"Meagher","year":"2018","journal-title":"Can. J. Cardiol."},{"issue":"11","key":"10.1016\/j.biopha.2024.116683_bib11","first-page":"918","article-title":"Relationship of nonalcoholic fatty liver disease and heart failure with preserved ejection fraction","volume":"6","author":"Salah","year":"2021","journal-title":"JACC: Basic Transl. Sci."},{"issue":"9","key":"10.1016\/j.biopha.2024.116683_bib12","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/ejhf.1956","article-title":"Regional adiposity and heart failure with preserved ejection fraction","volume":"22","author":"Rao","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.biopha.2024.116683_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/hep.28785","article-title":"The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.biopha.2024.116683_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-69013-y","article-title":"Prevalence and staging of non-alcoholic fatty liver disease among patients with heart failure with preserved ejection fraction","volume":"10","author":"Miller","year":"2020","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.biopha.2024.116683_bib15","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.metabol.2016.07.009","article-title":"Activin A and follistatin in patients with nonalcoholic fatty liver disease","volume":"65","author":"Polyzos","year":"2016","journal-title":"Metabolism"},{"issue":"9","key":"10.1016\/j.biopha.2024.116683_bib16","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1038\/ajg.2009.318","article-title":"A complex role of activin A in non-alcoholic fatty liver disease","volume":"104","author":"Yndestad","year":"2009","journal-title":"Am. J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116683_bib17","doi-asserted-by":"crossref","first-page":"9957","DOI":"10.1038\/s41598-018-27795-2","article-title":"Increased activin A levels in prediabetes and association with carotid intima-media thickness: a cross-sectional analysis from I-Lan Longitudinal Aging Study","volume":"8","author":"Kuo","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2024.116683_bib18","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1177\/1479164111431171","article-title":"Activin A and cardiovascular disease in type 2 diabetes mellitus","volume":"9","author":"Ueland","year":"2012","journal-title":"Diab. Vasc. Dis. Res."},{"key":"10.1016\/j.biopha.2024.116683_bib19","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.exger.2018.07.020","article-title":"Association between serum activin A and metabolic syndrome in older adults: potential of activin A as a biomarker of cardiometabolic disease","volume":"111","author":"Peng","year":"2018","journal-title":"Exp. Gerontol."},{"issue":"11","key":"10.1016\/j.biopha.2024.116683_bib20","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1161\/01.CIR.0000120704.97934.41","article-title":"2 Elevated levels of activin A in heart failure: potential role in myocardial remodeling","volume":"109","author":"Yndestad","year":"2004","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.biopha.2024.116683_bib21","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000318014","article-title":"Activin A in carcinoid heart disease: a possible role in diagnosis and pathogenesis","volume":"92","author":"Bergestuen","year":"2010","journal-title":"Neuroendocrinology"},{"issue":"11","key":"10.1016\/j.biopha.2024.116683_bib22","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1111\/jcmm.12344","article-title":"A pilot study of angiogenin in heart failure with preserved ejection fraction: a novel potential biomarker for diagnosis and prognosis?","volume":"18","author":"Jiang","year":"2014","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.biopha.2024.116683_bib23","first-page":"1","article-title":"Activin A levels in metabolic dysfunction-associated steatotic liver disease associates with fibrosis and the PNPLA3 I148M variant","author":"J\u00f6nsson","year":"2024","journal-title":"Scand. J. Gastroenterol."},{"issue":"8","key":"10.1016\/j.biopha.2024.116683_bib24","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1210\/en.2008-0922","article-title":"Activin signaling: effects on body composition and mitochondrial energy metabolism","volume":"150","author":"Li","year":"2009","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.biopha.2024.116683_bib25","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1152\/physrev.00002.2018","article-title":"Activin A in mammalian physiology","volume":"99","author":"Bloise","year":"2019","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2024.116683_bib26","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00125-011-2304-4","article-title":"Inhibition of myostatin protects against diet-induced obesity by enhancing fatty acid oxidation and promoting a brown adipose phenotype in mice","volume":"55","author":"Zhang","year":"2012","journal-title":"Diabetologia"},{"issue":"11","key":"10.1016\/j.biopha.2024.116683_bib27","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/ijo.2009.162","article-title":"The effects of a soluble activin type IIB receptor on obesity and insulin sensitivity","volume":"33","author":"Akpan","year":"2009","journal-title":"Int. J. Obes. (Lond.)"},{"issue":"1","key":"10.1016\/j.biopha.2024.116683_bib28","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.33457","article-title":"Effect of bimagrumab vs placebo on body fat mass among adults with type 2 diabetes and obesity: a phase 2 randomized clinical trial","volume":"4","author":"Heymsfield","year":"2021","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"10.1016\/j.biopha.2024.116683_bib29","doi-asserted-by":"crossref","first-page":"E41","DOI":"10.1152\/ajpendo.00389.2012","article-title":"Muscle protein synthesis, mTORC1\/MAPK\/Hippo signaling, and capillary density are altered by blocking of myostatin and activins","volume":"304","author":"Hulmi","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.biopha.2024.116683_bib30","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.ymthe.2019.01.013","article-title":"Systemic blockade of ACVR2B ligands protects myocardium from acute ischemia-reperfusion injury","volume":"27","author":"Magga","year":"2019","journal-title":"Mol. Ther."},{"issue":"7752","key":"10.1016\/j.biopha.2024.116683_bib31","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41586-019-1100-z","article-title":"Nitrosative stress drives heart failure with preserved ejection fraction","volume":"568","author":"Schiattarella","year":"2019","journal-title":"Nature"},{"issue":"149","key":"10.1016\/j.biopha.2024.116683_bib32","article-title":"Identification and dissection of diverse mouse adipose depots","author":"Bagchi","year":"2019","journal-title":"JoVE (J. Vis. Exp.)"},{"issue":"8","key":"10.1016\/j.biopha.2024.116683_bib33","doi-asserted-by":"crossref","first-page":"9911","DOI":"10.1096\/fj.201903074RR","article-title":"Systemic blockade of ACVR2B ligands attenuates muscle wasting in ischemic heart failure without compromising cardiac function","volume":"34","author":"Szab\u00f3","year":"2020","journal-title":"FASEB J."},{"issue":"7","key":"10.1016\/j.biopha.2024.116683_bib34","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"issue":"12","key":"10.1016\/j.biopha.2024.116683_bib35","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1194\/jlr.D023788","article-title":"Adiposoft: automated software for the analysis of white adipose tissue cellularity in histological sections","volume":"53","author":"Galarraga","year":"2012","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.biopha.2024.116683_bib36","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/hepr.12333","article-title":"Diagnosis and classification of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: current concepts and remaining challenges","volume":"45","author":"Hashimoto","year":"2015","journal-title":"Hepatol. Res."},{"issue":"6","key":"10.1016\/j.biopha.2024.116683_bib37","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.biopha.2024.116683_bib38","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/ehf2.12409","article-title":"The adipo-fibrokine activin A is associated with metabolic abnormalities and left ventricular diastolic dysfunction in obese patients","volume":"6","author":"Zeller","year":"2019","journal-title":"ESC Heart Fail"},{"issue":"10","key":"10.1016\/j.biopha.2024.116683_bib39","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.2337\/db10-0013","article-title":"Activin A plays a critical role in proliferation and differentiation of human adipose progenitors","volume":"59","author":"Zaragosi","year":"2010","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.biopha.2024.116683_bib40","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41419-021-03922-2","article-title":"Osteocrin, a novel myokine, prevents diabetic cardiomyopathy via restoring proteasomal activity","volume":"12","author":"Zhang","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2024.116683_bib41","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3389\/fphar.2017.00461","article-title":"Targeting TGF-\u03b2 mediated SMAD signaling for the prevention of fibrosis","volume":"8","author":"Walton","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116683_bib42","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1210\/jc.2015-3668","article-title":"Circulating follistatin is liver-derived and regulated by the glucagon-to-insulin ratio","volume":"101","author":"Hansen","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.biopha.2024.116683_bib43","doi-asserted-by":"crossref","first-page":"6486","DOI":"10.1038\/s41467-021-26536-w","article-title":"Elevated circulating follistatin associates with an increased risk of type 2 diabetes","volume":"12","author":"Wu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2024.116683_bib44","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.cca.2020.05.042","article-title":"Emerging role of Insig-1 in lipid metabolism and lipid disorders","volume":"508","author":"Ouyang","year":"2020","journal-title":"Clin. Chim. Acta"},{"issue":"29","key":"10.1016\/j.biopha.2024.116683_bib45","doi-asserted-by":"crossref","first-page":"18465","DOI":"10.1021\/acsomega.0c02350","article-title":"Glycerol-3-phosphate acyltransferase1 Is a model-agnostic node in nonalcoholic fatty liver disease: implications for drug development and precision medicine","volume":"5","author":"Liao","year":"2020","journal-title":"ACS Omega"},{"issue":"5","key":"10.1016\/j.biopha.2024.116683_bib46","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/HCO.0000000000000552","article-title":"Altered branched chain amino acid metabolism: toward a unifying cardiometabolic hypothesis","volume":"33","author":"Tobias","year":"2018","journal-title":"Curr. Opin. Cardiol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116683_bib47","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1210\/er.2012-1081","article-title":"Brown adipose tissue in adult humans: a metabolic renaissance","volume":"34","author":"Lee","year":"2013","journal-title":"Endocr. Rev."},{"issue":"4","key":"10.1016\/j.biopha.2024.116683_bib48","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1210\/jc.2015-4125","article-title":"Adipose tissue hypoxia, inflammation, and fibrosis in obese insulin-sensitive and obese insulin-resistant subjects","volume":"101","author":"Lawler","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.biopha.2024.116683_bib49","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.celrep.2014.12.023","article-title":"Adipose fatty acid oxidation is required for thermogenesis and potentiates oxidative stress-induced inflammation","volume":"10","author":"Lee","year":"2015","journal-title":"Cell Rep."},{"issue":"43","key":"10.1016\/j.biopha.2024.116683_bib50","doi-asserted-by":"crossref","first-page":"4420","DOI":"10.1093\/eurheartj\/ehab389","article-title":"Heart failure with preserved ejection fraction in humans and mice: embracing clinical complexity in mouse models","volume":"42","author":"Withaar","year":"2021","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.biopha.2024.116683_bib51","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/ar.20715","article-title":"Hepatic microcirculation in fatty liver disease","volume":"291","author":"Farrell","year":"2008","journal-title":"Anat. Rec.: Adv. Integr. Anat. Evolut. Biol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116683_bib52","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.bbadis.2017.12.031","article-title":"Activin-A causes hepatic stellate cell activation via the induction of TNF\u03b1 and TGF\u03b2 in Kupffer cells","volume":"1864","author":"Kiagiadaki","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"issue":"3","key":"10.1016\/j.biopha.2024.116683_bib53","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0016-5085(98)70539-6","article-title":"Expression of activin A is increased in cirrhotic and fibrotic rat livers","volume":"114","author":"Sugiyama","year":"1998","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.biopha.2024.116683_bib54","first-page":"279","article-title":"Adenovirus\u2011mediated knockdown of activin A receptor type 2A attenuates immune\u2011induced hepatic fibrosis in mice and inhibits interleukin\u201117\u2011induced activation of primary hepatic stellate cells","volume":"42","author":"Zhang","year":"2018","journal-title":"Int. J. Mol. Med."},{"issue":"2","key":"10.1016\/j.biopha.2024.116683_bib55","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1161\/ATVBAHA.122.318138","article-title":"Beneficial effects of moderate hepatic activin A expression on metabolic pathways, inflammation, and atherosclerosis","volume":"43","author":"Liu","year":"2023","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6613","key":"10.1016\/j.biopha.2024.116683_bib56","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1126\/science.abn0910","article-title":"Liver-heart cross-talk mediated by coagulation factor XI protects against heart failure","volume":"377","author":"Cao","year":"2022","journal-title":"Science"},{"issue":"18","key":"10.1016\/j.biopha.2024.116683_bib57","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell Mol. Life Sci."},{"issue":"9","key":"10.1016\/j.biopha.2024.116683_bib58","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/s41419-020-03003-w","article-title":"Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?","volume":"11","author":"Rada","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2024.116683_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101428","article-title":"CD36 promotes de novo lipogenesis in hepatocytes through INSIG2-dependent SREBP1 processing","volume":"57","author":"Zeng","year":"2022","journal-title":"Mol. Metab."},{"issue":"2","key":"10.1016\/j.biopha.2024.116683_bib60","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1210\/en.2015-1866","article-title":"Hepatocyte-specific disruption of CD36 attenuates fatty liver and improves insulin sensitivity in HFD-fed mice","volume":"157","author":"Wilson","year":"2016","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.biopha.2024.116683_bib61","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bbrc.2005.08.070","article-title":"Increased expression of PPAR\u03b3 in high fat diet-induced liver steatosis in mice","volume":"336","author":"Inoue","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"10.1016\/j.biopha.2024.116683_bib62","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.bbadis.2013.04.024","article-title":"Activation of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase during high fat diet feeding","volume":"1832","author":"Wu","year":"2013","journal-title":"Biochim. Biophys. Acta - Mol. Basis Dis."},{"issue":"1","key":"10.1016\/j.biopha.2024.116683_bib63","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4252\/wjsc.v6.i1.33","article-title":"Distinction of white, beige and brown adipocytes derived from mesenchymal stem cells","volume":"6","author":"Park","year":"2014","journal-title":"World J. Stem Cells"},{"issue":"2","key":"10.1016\/j.biopha.2024.116683_bib64","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrendo.2017.132","article-title":"Targeting thermogenesis in brown fat and muscle to treat obesity and metabolic disease","volume":"14","author":"Betz","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116683_bib65","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11154-021-09640-6","article-title":"The endocrine role of brown adipose tissue: an update on actors and actions","volume":"23","author":"Gavald\u00e0-Navarro","year":"2022","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.biopha.2024.116683_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2022.109002","article-title":"Progressive brown adipocyte dysfunction: whitening and impaired nonshivering thermogenesis as long-term obesity complications","volume":"105","author":"Rangel-Azevedo","year":"2022","journal-title":"J. Nutr. Biochem."},{"issue":"2","key":"10.1016\/j.biopha.2024.116683_bib67","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s13679-015-0157-8","article-title":"The whitening of brown fat and its implications for weight management in obesity","volume":"4","author":"Shimizu","year":"2015","journal-title":"Curr. Obes. Rep."},{"issue":"14","key":"10.1016\/j.biopha.2024.116683_bib68","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1128\/MCB.06575-11","article-title":"Blockade of the activin receptor IIb activates functional brown adipogenesis and thermogenesis by inducing mitochondrial oxidative metabolism","volume":"32","author":"Fournier","year":"2012","journal-title":"Mol. Cell. Biol."},{"issue":"9","key":"10.1016\/j.biopha.2024.116683_bib69","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1161\/ATVBAHA.114.303035","article-title":"Links between ectopic fat and vascular disease in humans","volume":"34","author":"Lim","year":"2014","journal-title":"Arterioscler.\u00a0Thromb.\u00a0Vasc. Biol."},{"issue":"26","key":"10.1016\/j.biopha.2024.116683_bib70","doi-asserted-by":"crossref","first-page":"E5266","DOI":"10.1073\/pnas.1620013114","article-title":"Specific targeting of TGF-\u03b2 family ligands demonstrates distinct roles in the regulation of muscle mass in health and disease","volume":"114","author":"Chen","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"13-14","key":"10.1016\/j.biopha.2024.116683_bib71","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.drudis.2012.02.001","article-title":"Myostatin: more than just a regulator of muscle mass","volume":"17","author":"Argil\u00e9s","year":"2012","journal-title":"Drug Discov. Today"},{"issue":"5","key":"10.1016\/j.biopha.2024.116683_bib72","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1172\/JCI0213562","article-title":"Suppression of body fat accumulation in myostatin-deficient mice","volume":"109","author":"McPherron","year":"2002","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.biopha.2024.116683_bib73","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/gerona\/glp068","article-title":"Myostatin inhibition enhances the effects of exercise on performance and metabolic outcomes in aged mice","volume":"64A","author":"LeBrasseur","year":"2009","journal-title":"J. Gerontol.: Ser. A"},{"issue":"12","key":"10.1016\/j.biopha.2024.116683_bib74","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S2213-8587(15)00298-3","article-title":"Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial","volume":"3","author":"Becker","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116683_bib75","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00125-011-2361-8","article-title":"Building muscle, browning fat and preventing obesity by inhibiting myostatin","volume":"55","author":"LeBrasseur","year":"2012","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.biopha.2024.116683_bib76","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1046\/j.1365-201X.2003.01167.x","article-title":"Fate of fatty acids at rest and during exercise: regulatory mechanisms","volume":"178","author":"Jensen","year":"2003","journal-title":"Acta Physiol. Scand."},{"issue":"5","key":"10.1016\/j.biopha.2024.116683_bib77","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/hep.30049","article-title":"Relationship between relative skeletal muscle mass and nonalcoholic fatty liver disease: a 7-year longitudinal study","volume":"68","author":"Kim","year":"2018","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.biopha.2024.116683_bib78","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12876-018-0776-0","article-title":"Relationship of sarcopenia with steatohepatitis and advanced liver fibrosis in non-alcoholic fatty liver disease: a meta-analysis","volume":"18","author":"Yu","year":"2018","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.biopha.2024.116683_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2021.01.016","article-title":"Relationship between muscle mass index and LDL cholesterol target levels: analysis of two studies of the Korean population","volume":"325","author":"Lee","year":"2021","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.biopha.2024.116683_bib80","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jacl.2020.01.002","article-title":"Skeletal muscle area and density are associated with lipid and lipoprotein cholesterol levels: the multi-ethnic study of atherosclerosis","volume":"14","author":"Vella","year":"2020","journal-title":"J. Clin. Lipidol."},{"issue":"49","key":"10.1016\/j.biopha.2024.116683_bib81","doi-asserted-by":"crossref","first-page":"30907","DOI":"10.1073\/pnas.2019263117","article-title":"Functional redundancy of type I and type II receptors in the regulation of skeletal muscle growth by myostatin and activin A","volume":"117","author":"Lee","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"27","key":"10.1016\/j.biopha.2024.116683_bib82","doi-asserted-by":"crossref","first-page":"21037","DOI":"10.1074\/jbc.M110.114959","article-title":"Characterization of the ligand binding functionality of the extracellular domain of activin receptor type IIb","volume":"285","author":"Sako","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2024.116683_bib83","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3389\/fphar.2018.00715","article-title":"c-Jun N-terminal kinases (JNKs) in myocardial and cerebral ischemia\/reperfusion injury","volume":"9","author":"Shvedova","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116683_bib84","doi-asserted-by":"crossref","first-page":"H378","DOI":"10.1152\/ajpheart.00302.2019","article-title":"Activin type II receptor ligand signaling inhibition after experimental ischemic heart failure attenuates cardiac remodeling and prevents fibrosis","volume":"318","author":"Castillero","year":"2020","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"6","key":"10.1016\/j.biopha.2024.116683_bib85","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1210\/en.2010-1328","article-title":"Osteopontin is an activator of human adipose tissue macrophages and directly affects adipocyte function","volume":"152","author":"Zeyda","year":"2011","journal-title":"Endocrinology"},{"issue":"10","key":"10.1016\/j.biopha.2024.116683_bib86","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1172\/JCI31986","article-title":"Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice","volume":"117","author":"Nomiyama","year":"2007","journal-title":"J. Clin. Investig."},{"issue":"8","key":"10.1016\/j.biopha.2024.116683_bib87","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1161\/CIRCULATIONAHA.117.031358","article-title":"Visceral adipose tissue drives cardiac aging through modulation of fibroblast senescence by osteopontin production","volume":"138","author":"Sawaki","year":"2018","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.biopha.2024.116683_bib88","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1210\/endrev\/bnab030","article-title":"Myostatin\/activin receptor ligands in muscle and the development status of attenuating drugs","volume":"43","author":"Rodgers","year":"2021","journal-title":"Endocr. Rev."},{"issue":"5","key":"10.1016\/j.biopha.2024.116683_bib89","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1053\/j.gastro.2017.12.024","article-title":"Effects of weight-loss medications on cardiometabolic risk profiles: a systematic review and network meta-analysis","volume":"154","author":"Khera","year":"2018","journal-title":"Gastroenterology"},{"issue":"10046","key":"10.1016\/j.biopha.2024.116683_bib90","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0140-6736(16)30175-1","article-title":"Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents","volume":"388","author":"Di Angelantonio","year":"2016","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.biopha.2024.116683_bib91","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41573-021-00337-8","article-title":"Anti-obesity drug discovery: advances and challenges","volume":"21","author":"M\u00fcller","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7","key":"10.1016\/j.biopha.2024.116683_bib92","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a021881","article-title":"Activins and inhibins: roles in development, physiology, and disease","volume":"8","author":"Namwanje","year":"2016","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"18","key":"10.1016\/j.biopha.2024.116683_bib93","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1016\/j.jacc.2017.09.028","article-title":"Interleukin-1 beta as a target for atherosclerosis therapy","volume":"70","author":"Libby","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"12","key":"10.1016\/j.biopha.2024.116683_bib94","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.biopha.2024.116683_bib95","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1038\/mt.2016.160","article-title":"GDF11 protects against endothelial injury and reduces atherosclerotic lesion formation in apolipoprotein E-null mice","volume":"24","author":"Mei","year":"2016","journal-title":"Mol. Ther."},{"issue":"3","key":"10.1016\/j.biopha.2024.116683_bib96","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1096\/fj.201801375RR","article-title":"GDF11 antagonizes TNF-\u03b1-induced inflammation and protects against the development of inflammatory arthritis in mice","volume":"33","author":"Li","year":"2019","journal-title":"FASEB"},{"key":"10.1016\/j.biopha.2024.116683_bib97","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.742178","article-title":"Inflammation in metabolic cardiomyopathy","volume":"8","author":"Wenzl","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"issue":"1","key":"10.1016\/j.biopha.2024.116683_bib98","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/01.RES.0000231290.45676.d4","article-title":"Myostatin regulates cardiomyocyte growth through modulation of Akt signaling","volume":"99","author":"Morissette","year":"2006","journal-title":"Circ. Res."},{"issue":"482","key":"10.1016\/j.biopha.2024.116683_bib99","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau8680","article-title":"Activin type II receptor signaling in cardiac aging and heart failure","volume":"11","author":"Roh","year":"2019","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.biopha.2024.116683_bib100","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/nm.3512","article-title":"Transforming growth factor-\u03b2 superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis","volume":"20","author":"Suragani","year":"2014","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.biopha.2024.116683_bib101","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/bjh.12838","article-title":"An activin receptor IIA ligand trap promotes erythropoiesis resulting in a rapid induction of red blood cells and haemoglobin","volume":"165","author":"Carrancio","year":"2014","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.biopha.2024.116683_bib102","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.biocel.2017.11.011","article-title":"Splenomegaly: pathophysiological bases and therapeutic options","volume":"94","author":"McKenzie","year":"2018","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"13","key":"10.1016\/j.biopha.2024.116683_bib103","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1056\/NEJMoa1910182","article-title":"A phase 3 trial of luspatercept in patients with transfusion-dependent \u03b2-thalassemia","volume":"382","author":"Cappellini","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.biopha.2024.116683_bib104","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1023\/A:1005446418589","article-title":"Spleen enlargement in patients with nonalcoholic fatty liver: correlation between degree of fatty infiltration in liver and size of spleen","volume":"45","author":"Tsushima","year":"2000","journal-title":"Dig. Dis. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2024.116683_bib105","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1080\/17474124.2021.1914587","article-title":"Liver-spleen axis in nonalcoholic fatty liver disease","volume":"15","author":"Tarantino","year":"2021","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116683_bib106","doi-asserted-by":"crossref","first-page":"8904","DOI":"10.4081\/ejtm.2020.8904","article-title":"Diminution in sperm quantity and quality in mouse models of Duchenne Muscular Dystrophy induced by a myostatin-based muscle growth-promoting intervention","volume":"30","author":"Vaughan","year":"2020","journal-title":"Eur. J. Transl. Myol."},{"issue":"6","key":"10.1016\/j.biopha.2024.116683_bib107","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/cen.13601","article-title":"Effects of bimagrumab, an activin receptor type II inhibitor, on pituitary neurohormonal axes","volume":"88","author":"Garito","year":"2018","journal-title":"Clin. Endocrinol. (Oxf.)"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224005675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224005675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T19:38:11Z","timestamp":1741030691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224005675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":107,"alternative-id":["S0753332224005675"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116683","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of activin receptor 2 signalling ameliorates metabolic dysfunction\u2013associated steatotic liver disease in western diet\/L-NAME induced cardiometabolic disease","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116683","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116683"}}